Compare ROIV & CSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROIV | CSL |
|---|---|---|
| Founded | 2014 | 1917 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 13.4B |
| IPO Year | N/A | N/A |
| Metric | ROIV | CSL |
|---|---|---|
| Price | $21.67 | $330.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | $21.94 | ★ $386.67 |
| AVG Volume (30 Days) | ★ 6.7M | 454.8K |
| Earning Date | 11-10-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 1.33% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 17.56 |
| Revenue | $20,329,000.00 | ★ $5,015,100,000.00 |
| Revenue This Year | N/A | $1.01 |
| Revenue Next Year | $376.94 | $2.69 |
| P/E Ratio | ★ N/A | $18.85 |
| Revenue Growth | N/A | ★ 0.14 |
| 52 Week Low | $8.73 | $293.43 |
| 52 Week High | $22.45 | $435.92 |
| Indicator | ROIV | CSL |
|---|---|---|
| Relative Strength Index (RSI) | 62.44 | 58.53 |
| Support Level | $20.14 | $318.33 |
| Resistance Level | $21.48 | $340.00 |
| Average True Range (ATR) | 0.71 | 7.85 |
| MACD | 0.00 | 2.46 |
| Stochastic Oscillator | 65.96 | 71.15 |
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Carlisle Companies Inc is a holding company. The company manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. The company is organized into two segments including Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company's product portfolio includes moisture protection products, protective roofing underlayments, integrated air and vapor barriers, spray polyurethane foam and coating systems, and others. The majority of the company's revenue comes from the Carlisle Construction Materials segment, and more than half of the total revenue is earned in the United States.